Results 331 to 340 of about 114,761 (352)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes

Diabetologia, 2020
Ulf Hannelius, Craig Beam, Johnny Ludvigsson   +2 more
exaly  

Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis

Cancer Immunology, Immunotherapy, 2013
Eishiro Mizukoshi, Masaaki Kitahara, Shuichi Kaneko   +2 more
exaly  

Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor

Nature Microbiology, 2019
Efstathios S Giotis, George William Carnell, Erik F Young   +2 more
exaly  

Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

Cancer Research, 2010
Isabel C Poschke, Dimitrios Mougiakakos, Giuseppe V Masucci   +2 more
exaly  

NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ

Immunogenetics, 2013
Ole Lund, Søren Buus, Morten Nielsen
exaly  

[Seminoma and HLA-DR antigens].

Casopis lekaru ceskych, 1988
A, Májský, J, Abrahámová
openaire   +1 more source

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer

Journal of Leukocyte Biology, 2013
Chris P Verschoor, Michael G Dorrington, Mark Loeb   +2 more
exaly  

CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway

Cancer Letters, 2014
Chun Guo, Yongyu Shi
exaly  

HLA-DR Antigen and IgA Nephropathy (Berger's Disease)

New England Journal of Medicine, 1980
R, Fauchet, M, Gueguen, B, Genetet, P, Le Pogamp, M P, Ramee, D, Chevet, P, Simon   +6 more
openaire   +2 more sources

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nature Genetics, 2019
Brian W Kunkle, Joshua C Bis, Vincent Damotte   +2 more
exaly